LIPO · Lipella Pharmaceuticals Inc. · Exempt Offerings
$0.00
+0.00 (+0.00%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— flagged Nov 14, 2025
Substantial doubt about the company's ability to continue as a going concern.
“These factors individually and collectively raise substantial doubt about the Company's ability to continue as a going concern. The accompanying unaudited condensed financial statements do not include any adjustments that may result from this uncertainty.”View the 10-Q filed Nov 14, 2025
Market Cap
$2,310
Shares
4.62M
Volume · Oct 2
594
Avg daily vol (3M)
19.71K
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2025-04-01 | New | Pharmaceuticals | $9,000 | $9,000 | 06b |
| 2025-01-07 | New | Pharmaceuticals | $6,000,000 | $2,597,500 | 06b |
| 2024-08-15 | New | Pharmaceuticals | $120,086 | $120,086 | 06b |
| 2023-11-07 | New | Pharmaceuticals | $2,000,000 | $2,000,000 | 06b |
| 2023-09-12 | New | Pharmaceuticals | $122,400 | $0 | 06b |
| 2021-05-17 | Amendment | Pharmaceuticals | $3,600,000 | $3,121,602 | 06b |
| 2021-04-12 | Amendment | Pharmaceuticals | $3,000,000 | $2,608,101 | 06b |
| 2020-11-04 | New | Pharmaceuticals | $3,000,000 | $405,000 | 06b |
Showing 1–8 of 8 filings